GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » FCF Yield %

Pet Pharm Biotech Co (ROCO:7762) FCF Yield % : -9.25 (As of Dec. 12, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Pet Pharm Biotech Co's Trailing 12-Month Free Cash Flow is NT$-155.3 Mil, and Market Cap is NT$1,655.6 Mil. Therefore, Pet Pharm Biotech Co's FCF Yield % for today is -9.25%.

The historical rank and industry rank for Pet Pharm Biotech Co's FCF Yield % or its related term are showing as below:

ROCO:7762' s FCF Yield % Range Over the Past 10 Years
Min: -10.41   Med: 0   Max: 0.68
Current: -9.25


During the past 2 years, the highest FCF Yield % of Pet Pharm Biotech Co was 0.68%. The lowest was -10.41%. And the median was 0.00%.

ROCO:7762's FCF Yield % is ranked worse than
77.09% of 1039 companies
in the Drug Manufacturers industry
Industry Median: 0.13 vs ROCO:7762: -9.25

Pet Pharm Biotech Co's FCF Margin % for the quarter that ended in Jun. 2024 was -292.12%.


Pet Pharm Biotech Co FCF Yield % Historical Data

The historical data trend for Pet Pharm Biotech Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co FCF Yield % Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23
FCF Yield %
- -

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
FCF Yield % - - - -

Competitive Comparison of Pet Pharm Biotech Co's FCF Yield %

For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pet Pharm Biotech Co's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Pet Pharm Biotech Co's FCF Yield % falls into.



Pet Pharm Biotech Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Pet Pharm Biotech Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=8.079 / 0
=N/A%

Pet Pharm Biotech Co's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-163.4 * 2 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pet Pharm Biotech Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Pet Pharm Biotech Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pet Pharm Biotech Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines